FDA Warns of Potential Mechanical Concerns With MAGEC Devices

Lucy Hicks

July 16, 2021

The US Food and Drug Administration (FDA) has issued a notice about potential mechanical failures and biocompatibility concerns with MAGEC system devices from NuVasive.

MAGEC is a surgical magnetic rod system used to treat early-onset scoliosis (EOS) in children under 10 years of age. The magnetic system can help avoid invasive surgeries, as growth rods can be adjusted with an external remote control. MAGEC is the only FDA-approved pure distraction-based system for EOS and is the most-used technology for EOS treatment in US, Aakash Agarwal, PhD, director of research and clinical affairs at Spinal Balance Inc in Swanton, Ohio told Medscape Medical News in an email.

According to the notice, there are reports of endcap separation and O-ring seal failure in the following six MAGEC devices:

  • MAGEC Spinal Bracing and Distraction System

  • MAGEC 2 Spinal Bracing and Distraction System

  • MAGEC System

  • MAGEC System Model X Device

  • MAGEC System Model X Rod

  • MAGEC System Rods

Endcap separation can potentially expose the patient's tissue to internal components of the device that have not been completely tested for biocompatibility.

In February 2020, NuVasive recalled its MAGEC System Model X rods to address reports of endcap separation issues. The FDA cleared a modified version of the device designed to mitigate these events in July 2020. In April of this year, NuVasive informed providers of potential biocompatibility concerns and placed a voluntary shipping hold on the MAGEC device system. The shipping hold was lifted yesterday, the company announced.

The FDA is currently not recommending removal of functioning MAGEC devices, noting that it is "in the best interest of patients" to continue to make the system available. The overall benefits of the device outweigh the known risks, and the restricted use for a 2-year implantation time for children under 10 years of age will further mitigate these risks, the FDA said in the statement.

To report adverse events related to MAGEC devices, patients, caregivers, and providers can submit a report through MedWatch, the FDA Safety Information and Adverse Event Reporting program.

For more news, follow Medscape on Facebook, Twitter, Instagram, YouTube, and LinkedIn


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.